Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 307 clinical trials
None
Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

- this study is being done to find out if the combination of carboplatin and gemcitabine will be more effective in the the treatment of advanced lung cancer if bevacizumab, an

carboplatin
gemcitabine
pleural effusion
bevacizumab
advanced lung cancer
  • 3 views
  • 07 Nov, 2020
  • 1 location
None
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

pigment epithelial and photoreceptor damage with visual impairment. The purpose of this clinical study is report the use of intravitreal bevacizumab is a new option in the treatment of

retinal pigment
angiography
fluorescein angiography
detachment
visual impairment
  • 3 views
  • 07 Nov, 2020
  • 1 location
None
Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery

This study analyzes the safety and efficacy of off-label Subconjunctival Injection of bevacizumab (Avastin) versus 0.02% mitomycin C (MMC) for preventing bleb failure following glaucoma

trabeculectomy
mitomycin
subconjunctival injection
cataract
angle closure glaucoma
  • 28 views
  • 07 Nov, 2020
  • 1 location
None
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome

bevacizumab in the treatment of retinopathy of prematurity

blindness
vegf
vascular endothelial growth factor
bevacizumab
antiangiogenic therapy
  • 4 views
  • 07 Nov, 2020
  • 1 location
None
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

The purpose of this study is to determine if of combination therapy of intravitreal bevacizumab 4 days after the application of photodynamic therapy could improve the visual outcomes of

photodynamic therapy
age-related macular degeneration
bevacizumab
corrected visual acuity
verteporfin
  • 17 views
  • 07 Nov, 2020
  • 1 location
None
Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy

The purpose of the study is to evaluate the safety and efficacy of 2.5 mg of intravitreal bevacizumab in one eye, versus panretinal photocoagulation in the contralateral eye, for the

photocoagulation
retinopathy
bevacizumab
diabetic retinopathy
proliferative diabetic retinopathy
  • 18 views
  • 07 Nov, 2020
  • 1 location
None
Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

. Therefore, investigators generate the hypothesis that adding vascular endothelial growth factor (VEGF) monoclonal antibody, Bevacizumab, to standard neoadjuvant CCRT may improve outcome for patients with

  • 0 views
  • 23 Jan, 2021
  • 1 location
None
Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma

The aim of this study is to make preliminary assessment of PD-L1 and other immune related biomarkers that might act as predictors of anti-tumor activity of Nivolumab in patients with recurrent glioblastoma

recurrent glioblastoma
corticosteroids
glioblastoma multiforme
platelet count
measurable disease
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose

injections, laser selective hmostatses , embolization or surgical dermoplasties ) allow for some short-term remissions . Bevacizumab is an antiangiogenic use in the treatment of colorectal cancers . It is

epistaxis
arteriovenous malformation
blood transfusion
bevacizumab
glaucoma
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Nab-paclitaxel Combined With Bevacizumab in the Treatment of Metastatic Neuroendocrine Carcinoma

This is an open-label, phase II study evaluating efficacy and safety of Nab-paclitaxel Combined With Bevacizumab for unresectable Recurrent or metastatic neuroendocrine carcinoma.

  • 0 views
  • 31 Jan, 2021
  • 1 location